Differential sleep effects of eszopiclone treatment and discontinuation in patients with primary insomnia and insomnia co-existing with major depressive disorder (MDD) or generalized anxiety disorder (GAD)

被引：0
|
作者：
Fava, M. [1 ]
Schaefer, K. [3 ]
Rockett, C. B. [4 ]
Amato, D. [3 ]
Roth, T. [2 ]
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Henry Ford Sleep Disorders Ctr, Detroit, MI USA
[3] Sepracor Inc, Marlborough, MA USA
[4] GlaxoSmithKline Inc, Durham, NC USA
来源：
JOURNAL OF SLEEP RESEARCH | 2008年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：192 / 192
页数：1
相关论文
共 50 条
  • [1] Differential sleep effects of eszopiclone treatment and discontinuation in patients with primary insomnia and insomnia co-existing with major depressive disorder or generalized anxiety disorder
    Krystal, A.
    Schaefer, K.
    Rockett, C.
    Fava, M.
    Amato, D.
    Roth, T.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 306 - 306
  • [2] Sleep outcomes following eszopiclone discontinuation in patients with primary insomnia and insomnia co-existing with major depressive disorder or generalized anxiety disorder
    Krystal, A.
    Fava, M.
    Pollack, M.
    Rubens, R.
    Schaefer, K.
    Amato, D.
    Roth, T.
    [J]. SLEEP, 2007, 30 : A245 - A245
  • [3] Sleep outcomes following eszopiclone discontinuation in patients with primary insomnia co-existing with major depressive disorder or generalized anxiety disorder
    Krystal, Andrew
    Fava, Maurizio
    Pollack, Mark
    Rubens, Robert
    Schaefer, Kendyl
    Amato, David
    Roth, Thomas
    [J]. BIOLOGICAL PSYCHIATRY, 2007, 61 (08) : 84S - 84S
  • [4] Eszopiclone co-administered with fluoxetine for insomnia co-existing with major depressive disorder (MDD): Analysis by severity of insomnia
    McCall, V
    Krystal, A.
    Fava, M.
    Rubens, R.
    Schaefer, K.
    Huang, H.
    Amato, D.
    Roth, T.
    [J]. SLEEP, 2006, 29 : A249 - A249
  • [5] Eszopiclone co-administered with fluoxetine for insomnia co-existing with major depressive disorder (MDD): a subgroup analysis
    Roth, T.
    Mccall, W.
    Wessel, T.
    Amato, D.
    Paska, W.
    Fava, M.
    [J]. JOURNAL OF SLEEP RESEARCH, 2008, 17 : 191 - 192
  • [6] Eszopiclone co-administered with fluoxetine for insomnia co-existing with major depressive disorder (MDD): A subgroup analysis
    Fava, M.
    McCall, W. V.
    Wessel, T.
    Amato, D.
    Paska, W.
    Montgomery, S.
    Roth, T.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 306 - 306
  • [7] Eszopiclone co-administered with fluoxetine for insomnia associated with major depressive disorder (MDD): Effects following eszopiclone discontinuation
    Krystal, A
    Rubens, R
    Fava, M
    McCall, V
    Wessel, T
    Amato, D
    Caron, J
    Roth, T
    [J]. SLEEP, 2005, 28 : A311 - A311
  • [8] Changes in sleep outcomes with hypnotic placebo in patients with primary insomnia (PI) and insomnia co-morbid with major derpessive disorder (MDD) or generalized anxiety disorder (GAD)
    Rubens, Robert
    McCall, W. Vaughn
    Wilson, Phebe
    Schaefer, Kendyl
    Fava, Maurizio
    Pollack, Mark
    Roth, Thomas
    [J]. BIOLOGICAL PSYCHIATRY, 2007, 61 (08) : 85S - 85S
  • [9] Eszopiclone co-administered with escitalopram oxalate for insomnia co-existing with generalized anxiety disorder (GAD): A subgroup analysis
    Cooper, J.
    Pinette, K.
    Montgomery, S.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 306 - 306
  • [10] Eszopiclone co-administered with fluoxetine for insomnia associated with major depressive disorder (MDD): Sleep effects
    Buysse, D
    McCall, V
    Roach, J
    Wessel, T
    Wilson, P
    Caron, J
    Roth, T
    [J]. SLEEP, 2005, 28 : A310 - A311
12345